Skip to content
★ Sign in to follow
IF

Ian F. Smith

Board Director
Director
Solid Biosciences Inc.Vertex Pharmaceuticals INC / MAAcorda Therapeutics IncInfinity Pharmaceuticals, Inc.
Total declarations
273
Companies
4
▲ Purchases (0 ops.)
—
▼ Sales (152 ops.)
€134.3M

Latest filing published 06 Oct 2026 for Solid Biosciences Inc..

Filing timeline

BuySale
Ian F. Smith

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
152
Signal history

Ian F. Smith: trading record in brief

Ian F. Smith (board member) discloses dealings in 4 companies, chiefly Vertex Pharmaceuticals INC / MA, Solid Biosciences Inc. and Acorda Therapeutics Inc. Over a trading history stretching from 23 January 2006 to 2 October 2026, the count stands at 273 filings.

Every open-market trade on record is a sale: 152 sales worth €134.3M. The rest of the record consists of 21 share grants and 100 option exercises.

On 6 October 2026 came the latest disclosure, an option exercise in Solid Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ian F. Smith

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations267 total

25 of 267 declarations